Exchange: OTC·Updated 10:11 AM EDT

IDRSF Idorsia Ltd

$7.25
$0.06
(0.82%)
Today
EarningsOct 29
Mkt Cap$1.92B
Vol13,000.00

About IDRSF

Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and EUCAN. The company was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.
50

Neutral Sentiment

How do you feel about IDRSF?

Advertisement|Remove ads.